Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Desgagné

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Organic Letters|December 8, 2025
Orthogonal Cleavage of the HMPB Linker from Solid Support Using HFIPMichael Desgagné, Dennis A Kutateladze, Bradley L Pentelute
Molecules (Basel, Switzerland)|May 14, 2022
Efficient Fmoc-Protected Amino Ester Hydrolysis Using Green Calcium(II) Iodide as a Protective AgentRenaud Binette, Michael Desgagné, Camille Theaud, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|December 21, 2022
Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain managementSanto Previti, Michael Desgagné, Dirk Tourwé, et al.
Bioorganic Chemistry|December 13, 2024
Diversity-oriented synthesis of second generation guanidinium-rich transporters toward cell-selective penetrationDuc Tai Nguyen, Michael Desgagné, Andréanne Laniel, et al.
Molecules (Basel, Switzerland)|July 14, 2023
The Therapeutic Value of Solanum Steroidal (Glyco)Alkaloids: A 10-Year Comprehensive ReviewJulien A Delbrouck, Michael Desgagné, Christian Comeau, et al.
Journal of Medicinal Chemistry|February 4, 2021
Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid AnalgesicMagali Chartier, Michael Desgagné, Marc Sousbie, et al.
Journal of Medicinal Chemistry|December 5, 2025
Structure-Guided Optimization of Selective Covalent Reversible Peptidomimetic Inhibitors Targeting TMPRSS6Walid Guerrab, Matthieu Lepage, Antoine Désilets, et al.
Journal of Medicinal Chemistry|February 28, 2024
Insights on Structure-Passive Permeability Relationship in Pyrrole and Furan-Containing MacrocyclesHuy M Ly, Michael Desgagné, Duc Tai Nguyen, et al.
Pharmacological Research|September 22, 2024
Multitarget ligands that comprise opioid/nonopioid pharmacophores for pain management: Current state of the scienceÉmile Breault, Michael Desgagné, Jolien De Neve, et al.
Angewandte Chemie (International Ed. in English)|August 7, 2024
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid-Free AnalgesicsMichael Desgagné, Magali Chartier, Camille Lagard, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Organic Letters|December 8, 2025
Orthogonal Cleavage of the HMPB Linker from Solid Support Using HFIPMichael Desgagné, Dennis A Kutateladze, Bradley L Pentelute
Molecules (Basel, Switzerland)|May 14, 2022
Efficient Fmoc-Protected Amino Ester Hydrolysis Using Green Calcium(II) Iodide as a Protective AgentRenaud Binette, Michael Desgagné, Camille Theaud, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|December 21, 2022
Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain managementSanto Previti, Michael Desgagné, Dirk Tourwé, et al.
Bioorganic Chemistry|December 13, 2024
Diversity-oriented synthesis of second generation guanidinium-rich transporters toward cell-selective penetrationDuc Tai Nguyen, Michael Desgagné, Andréanne Laniel, et al.
Molecules (Basel, Switzerland)|July 14, 2023
The Therapeutic Value of Solanum Steroidal (Glyco)Alkaloids: A 10-Year Comprehensive ReviewJulien A Delbrouck, Michael Desgagné, Christian Comeau, et al.
Journal of Medicinal Chemistry|February 4, 2021
Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid AnalgesicMagali Chartier, Michael Desgagné, Marc Sousbie, et al.
Journal of Medicinal Chemistry|December 5, 2025
Structure-Guided Optimization of Selective Covalent Reversible Peptidomimetic Inhibitors Targeting TMPRSS6Walid Guerrab, Matthieu Lepage, Antoine Désilets, et al.
Journal of Medicinal Chemistry|February 28, 2024
Insights on Structure-Passive Permeability Relationship in Pyrrole and Furan-Containing MacrocyclesHuy M Ly, Michael Desgagné, Duc Tai Nguyen, et al.
Pharmacological Research|September 22, 2024
Multitarget ligands that comprise opioid/nonopioid pharmacophores for pain management: Current state of the scienceÉmile Breault, Michael Desgagné, Jolien De Neve, et al.
Angewandte Chemie (International Ed. in English)|August 7, 2024
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid-Free AnalgesicsMichael Desgagné, Magali Chartier, Camille Lagard, et al.
Pageof 2